Five-year outcomes of a drug-coated polymer-free biolimus-eluting stent versus an ultrathin-strut biodegradable-polymer sirolimus-eluting stent
Five-year TLF did not differ significantly between the drug-coated biolimus-eluting stent group and the ultrathin-strut biodegradable-polymer stent group, but the risk of TLR was higher in the drug-coated biolimus-eluting stent group.
Authors
- Jens Flensted Lassen (ORCID: https://orcid.org/0000-0001-7972-9192)
- Karsten Tange Veien (ORCID: https://orcid.org/0000-0002-3898-9331)
- Evald Høj Christiansen (ORCID: https://orcid.org/0000-0002-8740-4862)
- Julia Ellert‐Gregersen (ORCID: https://orcid.org/0000-0001-5985-5538)
- Lars Jakobsen (ORCID: https://orcid.org/0000-0002-2522-9253)
- Anders Ellekaer Junker (ORCID: https://orcid.org/0000-0002-4804-8308)
- Thomas Engstrøm (ORCID: https://orcid.org/0000-0001-5436-9194)
- Rebekka Vibjerg Jensen (ORCID: https://orcid.org/0000-0001-6539-5275)
- Lisette Okkels Jensen (ORCID: https://orcid.org/0000-0002-4838-2429)
- Phillip Freeman (ORCID: https://orcid.org/0000-0003-1769-251X)
- Ashkan Eftekhari (ORCID: https://orcid.org/0000-0003-2871-8279)
- Nicolaj Brejnholt Støttrup
- Johnny Kahlert
Institutions
- Aarhus University (DK)
- Aalborg University Hospital (DK)
- Odense University Hospital (DK)
- Aarhus University Hospital (DK)
- Rigshospitalet (DK)
Publication Details
- Journal
- EuroIntervention
- Published
- 2025-05-26
- DOI
- https://doi.org/10.4244/eij-d-24-00586
- Citations
- 3
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 6.02